Corticotropin-releasing factor modulation of forebrain gabaergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse

Neuropsychopharmacology

Volumn 37, Issue 6, 2012, Pages 1483-1499

  Oberlander, Joseph G ^a   Henderson, Leslie P ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

acoustic startle response; anabolic steroids; anxiety; corticotropin releasing factor; extended amygdala; GABAA receptor

Indexed keywords

ANABOLIC AGENT; ANTALARMIN; CORTICOTROPIN RELEASING FACTOR; PROTEIN C FOS;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GABAERGIC TRANSMISSION; MOUSE; NEUROPIL; NONHUMAN; PRIORITY JOURNAL;

ACOUSTIC STIMULATION; ACTION POTENTIALS; AMYGDALA; ANALYSIS OF VARIANCE; ANDROGENS; ANIMALS; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GABAERGIC NEURONS; INHIBITORY POSTSYNAPTIC POTENTIALS; INJECTIONS, INTRAVENTRICULAR; MICE; MICE, INBRED C57BL; PATCH-CLAMP TECHNIQUES; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS C-FOS; PYRIMIDINES; PYRROLES; RNA, MESSENGER; SENSORY GATING; TIME FACTORS;

EID: 84859763592     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.334     Document Type: Article

References (170)

1. Agis-Balboa RC, Pibiri F, Nelson M, Pinna G (2009). Enhanced fear responses in mice treated with anabolic androgenic steroids. Neuroreport 20(6): 617-621.
2. A° gren G, Thiblin I, Tirassa P, Lundeberg T, Stenfors C (1999). Behavioural anxiolytic effects of low-dose anabolic androgenic steroid treatment in rats. Physiol Behav 66: 503-509.
3. Aikey JL, Nyby JG, Anmuth DM, James PJ (2002). Testosterone rapidly reduces anxiety in male house mice (Mus musculus). Horm Behav 42: 448-460. (Pubitemid 36071179)
4. Alheid GF (2003). Extended amygdala and basal forebrain. Ann NY Acad Sci 985: 185-205. (Pubitemid 36521116)
5. Ambar G, Chiavegatto S (2009). Anabolic-androgenic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice. Genes Brain Behav 8: 161-173.
6. Annitto WJ, Layman WA (1980). Anabolic steroids and acute schizophrenic episode. J Clin Psychiatry 41(4): 143-144. (Pubitemid 10153359)
7. Arluison M, Brochier G, Vankova M, Leviel V, Villalobos J, Tramu G (1994). Demonstration of peptidergic afferents to the bed nucleus of the stria terminalis using local injections of colchicine. A combined immunohistochemical and retrograde tracing study. Brain Res Bull 34(4): 319-337. (Pubitemid 24156798)
8. Asan E, Yilmazer-Hanke DM, Eliava M, Hantsch M, Lesch KP, Schmitt A (2005). The corticotrophin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison in the rat. Neuroscience 131: 953-967. (Pubitemid 40320946)
9. Bahrke MS, Yesalis CE (2004). Abuse of anabolic androgenic steroids and related substances in sport and exercise. Curr Opin Pharmacol 4(6): 614-620. (Pubitemid 40267877)
10. Bahrke MS, Yesalis CE, Kopstein AN, Stephens JA (2000). Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Med 29(6): 397-405. (Pubitemid 30392020)
11. Bajo M, Cruz MT, Siggins GR, Messing R, Roberto M (2008). Protein kinase C epsilon mediation of CRF-and ethanol-induced GABA release in central amygdala. Proc Natl Acad Sci USA 105: 8410-8415. (Pubitemid 351904770)
12. Bale TL, Vale WW (2004). CRF and CRF receptors: Role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525-557. (Pubitemid 38263852)
13. Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H et al. (2010). Sex differences in corticotropinreleasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 15(9): 896-904.
14. Baram TZ, Chalmers DT, Chen C, Koutsoukos Y, De Souza EB (1997). The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res 770: 89-95. (Pubitemid 27468055)
15. Barreto-Estrada JL, Barreto J, Fortis-Santiago Y, Rivera-Ramos I, Fortis-Santiago A, Jorge JC (2004). Modulation of affect after chronic exposure to the anabolic steroid 17a-methyltestosterone in adult mice. Behav Neurosci 118: 1071-1079. (Pubitemid 39346512)
16. Basaria S (2010). Androgen abuse in athletes: detection and consequences. J Clin Endocrinol Metab 95(4): 1533-1543.
17. Basaria S, Wahlstrom JT, Dobs AS (2001). Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 86: 5108-5117. (Pubitemid 33070222)
18. Bingham B, Myung C, Innala L, Gray M, Anonuevo A, Viau V (2011). Androgen receptors in the posterior bed nucleus of the stria terminalis increase neuropeptide expression and the stressinduced activation of the paraventricular nucleus of the hypothalamus. Neuropsychopharmacology 36: 1433-1443.
19. Bitran D, Kellogg CK, Hilvers RJ (1993). Treatment with an anabolic-androgenic steroid affects anxiety-related behavior and alters the sensitivity of cortical GABAA receptors in the rat. Horm Behav 27: 568-583. (Pubitemid 24003825)
20. Blank T, Nijholt I, Grammatopoulos DK, Randeva HS, Hillhouse EW, Spiess J (2003). Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J Neurosci 23(2): 700-707. (Pubitemid 36139569)
21. Blasberg ME, Clark AS (1997). Anabolic-androgenic steroid effects on sexual receptivity in ovariectomized rats. Horm Behav 32: 201-208. (Pubitemid 28079091)
22. Briscoe RJ, Cabrera CL, Baird TJ, Rice KC, Woods JH (2000). Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats. Brain Res 881(2): 204-207.
23. Brower KJ, Blow FC, Young JP, Hill EM (1991). Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict 86(6): 759-768.
24. Burnett KF, Kleiman ME (1994). Psychological characteristics of adolescent steroid users. Adolescence 29(113): 81-89.
25. Campbell RE, Han SK, Herbison AE (2005). Biocytin filling of adult gonadotropin-releasing hormone neurons in situ reveals extensive, spiny, dendritic processes. Endocrinology 146(3): 1163-1169. (Pubitemid 40289305)
26. Carrillo M, Ricci LA, Melloni RH (2011). Glutamate and the aggression neural circuit in adolescent anabolic steroid-treated Syrian hamsters (Mesocricetus auratus). Behav Neurosci 125(5): 753-763.
27. Cassell MD, Freedman LJ, Shi C (1999). The intrinsic organization of the central extended amygdala. Ann N Y Acad Sci 877: 217-241. (Pubitemid 29351860)
28. Chung C, Barylko B, Leitz J, Liu X, Kavalali ET (2010). Acute dynamin inhibition dissects synaptic vesicle recycling pathways that drive spontaneous and evoked neurotransmission. J Neurosci 30(4): 1363-1376.
29. Clark AS, Costine BA, Jones BL, Kelton-Rehkopf MC, Meerts SH, Nutbrown-Greene LL et al. (2006). Sex-and age-specific effects of anabolic androgenic steroids on reproductive behaviors and on GABAergic transmission in neuroendocrine control regions. Brain Res 1126: 122-138. (Pubitemid 44889244)
30. Clark AS, Henderson LP (2003). Behavioral and physiological responses to anabolic-androgenic steroids. Neurosci Biobehav Rev 27(5): 413-436. (Pubitemid 37167993)
31. Clark AS, Jones BL, Yang P, Henderson LP (2004). Anabolic androgenic steroids and the brain: novel actions at the GABAA receptor and on GABAA receptor mediated-behaviors. In: Smith, SS (ed). Neurosteroid Effects in the Central Nervous System: The Role of the GABAA Receptor. CRC Press: LLC pp 119-141.
32. Clayton DF (2000). The genomic action potential. Neurobiol Learn Mem 74(3): 185-216.
33. Collingridge GL, Peineau S, Howland JG, Wang YT (2010). Longterm depression in the CNS. Nat Neurosci Revs 11: 459-473.
34. Conrad KL, Winder DG (2011). Altered anxiety-like behavior and long-term potentiation in the bed nucleus of the stria terminalis in adult mice exposed to chronic social isolation, unpredictable stress, and ethanol beginning in adolescence. Alcohol 45(6): 585-593.
35. Cooper CJ, Noakes TD, Dunne T, Lambert MI, Rochford K (1996). A high prevalence of abnormal personality traits in chronic users of anabolic-androgenic steroids. Br J Sports Med 30(3): 246-250. (Pubitemid 26326584)
36. Cooper RL, Goldman JM, Vandenbergh JG (1993). Monitoring of the Estrous Cycle in the Laboratory Rodent by Vaginal Lavage. In: Heindel JJ, Chapin RE (eds). Methods in Toxicology. Academic Press: New York, NY, pp 45-55.
37. Costine BA, Oberlander JG, Davis MC, Penatti CAA, Porter DM, Leaton RN et al. (2010). Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse. Psychoneuroendocrinology 35(10): 1473-1485.
38. Daly RC, Su TP, Schmidt PJ, Pickar D, Murphy DL, Rubinow DR (2001). Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings. Arch Gen Psychiatry 58: 172-177. (Pubitemid 32142755)
39. Davis M, Walker DL, Lee Y (1997). Amygdala and bed nucleus of the stria terminalis: differtial roles in fear and anxiety measured with the acoustic startle reflex. Philos Trans R Soc Lond B Biol Sci 352(1362): 1675-1687. (Pubitemid 28000461)
40. Davis M, Walker DL, Miles L, Grillon C (2010). Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35: 105-135.
41. Day HEW, Curran EJ, Watson SJ, Akil H (1999). Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1b. J Comp Neurol 413: 113-128. (Pubitemid 29409755)
42. Deak T, Meriwether JL, Fleshner M, Spencer RL, Abouhamze A, Moldawer LL et al. (1998). Evidence that brief stress may induce the acute phase response in rats. Am J Physiol 273(6 Pt 2): R1998-R2004.
43. Diamond DM, Park CR, Campbell AM, Woodson JC (2005). Competitive interactions between endogenous LTD and LTP in the hippocampus underlie the storage of emotional memories and stress-induced amnesia. Hippocampus 15: 1006-1025. (Pubitemid 43056990)
44. Dodge T, Hoagland MF (2011). The use of anabolic androgenic steroids and polypharmacy: A review of the literature. Drug Alcohol Depend 114: 100-109.
45. Dong HW, Petrovich GD, Swanson LW (2001). Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Revs 38: 192-246. (Pubitemid 34066502)
46. Dong HW, Swanson LW (2005). Organization of axonal projections from the anterolateral area of the bed nucleus of the stria terminalis. J Comp Neurol 468: 277-298.
47. Egli RE, Winder DG (2003). Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J Neurophysiol 90: 405-414.
48. Elliot DL, Cheong JW, Moe EL, Goldberg L (2007). Cross-sectional study of female students reporting anabolic steroid use. Arch Pediatr Adolesc Med 161: 572-577. (Pubitemid 46878683)
49. Erb S, Salmaso N, Rodaros D, Stewart J (2001). A role for the CRFcontaining pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology 158: 360-365. (Pubitemid 33141311)
50. Erb S, Stewart J (1999). A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropinreleasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19(RC35): 106.
51. Forger NG, Rosen GJ, Waters EM, Jacob D, Simerly RB, de Vries GJ (2004). Deletion of Bax eliminates sex differences in the mouse forebrain. Proc Natl Acad Sci USA 101(37): 13666-13671. (Pubitemid 39238460)
52. Franke WW, Berendonk B (1997). Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 43: 1262-1279. (Pubitemid 27297278)
53. Franklin KJB, Paxinos G (1997). The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, CA.
54. Fredj NB, Burrone J (2009). A resting pool of vesicles is responsible for spontaneous vesicle fusion at the synapse. Nat Neurosci 12(6): 751-758.
55. Frye CA, Edinger KL, Sumida K (2008a). Androgen administration to aged male mice increases anti-anxiety behavior and enhances cognitive performance. Neuropsychopharmacology 33: 1049-1061. (Pubitemid 351367554)
56. Frye CA, Koonce CJ, Edinger KL, Osborne DM, Walf AA (2008b). Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm Behav 54(5): 726-734.
57. Gallagher JP, Orozco-Cabal LF, Liu J, Shinnick-Gallagher P (2008). Synaptic physiology of central CRH system. Eur J Pharmacol 583: 215-225.
58. Galligani N, Renck A, Hansen S (1996). Personality profile of men using anabolic androgenic steroids. Horm Behav 30(2): 170-175. (Pubitemid 26227735)
59. Gray TS, Bingaman EW (1996). The amygdala: corticotropinreleasing factor, steroids, and stress. Crit Rev Neurobiol 10(2): 155-168.
60. Grimes JM, Melloni Jr RH (2005). Serotonin-1B receptor activity and expression modulate the aggression-stimulating effects of adolescent anabolic steroid exposure in hamsters. Behav Neurosci 119(5): 1184-1194. (Pubitemid 41598731)
61. Hall RC, Chapman MJ (2005). Psychiatric complications of anabolic steroid abuse. Psychosomatics 46(4): 285-290. (Pubitemid 41472626)
62. Hammack SE, Guo JD, Hazra R, Dabrowska J, Myers KM, Rainnie DG (2009). The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety. Prog Neuropsychopharmacol Biol Pyschiatry 33(8): 1309-1320.
63. Hammack SE, Irakli M, Ainnie DG (2007). Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol 98: 638-656. (Pubitemid 47236021)
64. Handa RJ, Nunley KM, Lorens SA, Louie JP, McGivern RF, Bollnow MR (1994). Androgen regulation of adrenocorticotropin and corticosterone secretion in the male rat following novelty and foot shock stressors. Physiol Behav 55(1): 117-124.
65. Handa RJ, Weiser MJ, Zuloaga DG (2009). A role for the androgen metabolite, 5a-androstane-3b,17b-diol in modulating oestrogen receptor b-mediated regulation of hormonal stress reactivity. Neuroendocrinology 21: 351-358.
66. Hazra R, Guo JD, Ryan SJ, Jasnow AM, Dabrowska J, Rainnie DG (2011). A transcriptome analysis of type I-III neurons in the bed nucleus of the stria terminalis. Molec Cell Neurosci 46: 699-709.
67. Henderson LP (2007). Steroid modulation of GABAA receptormediated transmission in the hypothalamus: Effects on reproductive function. Neuropharmacology 52: 1439-1453. (Pubitemid 46678081)
68. Henderson LP, Jorge JC (2004). Steroid modulation of GABAA receptors: CNS roles in reproduction, dysfunction and drug abuse. In: Maue RA (ed). Advances in Molecular and Cell Biology. Molecular Insights into Ion Channel Biology in Health and Disease: Elsevier, vol. 32 pp 217-249.
69. Herman JP, Prewitt CM, Cullinan WE (1996). Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stresss axis. Crit Rev Neurobiol 10: 371-394. (Pubitemid 27036104)
70. Hoffman GE, Smith MS, Verbalis JG (1993). c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol 14(3): 173-213. (Pubitemid 23195792)
71. Holsboer F, Ising M (2008). Central CRH system in depression and anxiety-evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583: 350-357.
72. Howland JG, Wang YT (2008). Synaptic plasticity in learning and memory: stress effects in the hippocampus. Prog Brain Res 169: 145-158. (Pubitemid 351451901)
73. Hyytiä P, Koob GF (1995). GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur J Pharmacol 283: 151-159.
74. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE (2009). Monitoring the Future National Survey Results on Drug Use, 1975-2008. Volume I: Secondary School Students (NIH Publication No. 09-7402). National Institute on Drug Abuse: Bethesda, MD.
75. Justice NJ, Yuan ZF, Sawchenko PE, Vale W (2008). Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: Implications for reconciling ligandreceptor mismatch in the central corticotropin-releasing factor system. J Comp Neurol 511: 479-496.
76. Kageyama K, Suda T (2009). Regulatory mechanisms underlying corticotropin-releasing factor gene expression in the hypothalamus. Endocrine J 56(3): 335-344.
77. Kanayama G, Hudson JI, Pope HG (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend 98: 1-12.
78. Kash TL, Winder DG (2006). Neuropeptide Y and corticotropinreleasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51: 1013-1022. (Pubitemid 44528607)
79. Kim JJ, Song EY, Kosten TA (2006). Stress effects in the hippocampus: synaptic plasticity and memory. Stress 9(1): 1-11. (Pubitemid 43861155)
80. Kirby LG, Freeman-Daniels E, Lemos JC, Nunan JD, Lamy C, Akanwa A et al. (2008). Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-Hydroxytryptamine dorsal raphe neurons. J Neurosci 28(48): 12927-12937.
81. Korosi A, Baram TZ (2008). The central corticotropin releasing factor system during development and adulthood. Eur J Pharmacol 583: 204-214.
82. Kouvelas D, Pourzitaki C, Papazisis G, Dagklis T, Dimou K, Kraus MM (2008). Nandrolone abuse decreases anxiety and impairs memory in rats via central androgenic receptors. Int J Neuropsychopharmacol 11: 925-934.
83. Krettek JE, Price JL (1978). Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J Comp Neurol 178: 225-254.
84. Lalmansingh AS, Uht RM (2010). Estradiol regulates corticotropinreleasing hormone gene (crh) expression in a rapid and phasic manner that parallels estrogen receptor-a and-b recruitment to a 30,50-cyclic adenosine 50-monophosphate regulatory region of the proximal crh promoter. Endocrinology 149(1): 346-357.
85. Lammel S, Ion DI, Roeper J, Malenka RC (2011). Projectionspecific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 70(5): 855-862.
86. Laviola G, Macri S, Morley-Fletcher S, Adriani W (2003). Risktaking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Revs 27: 19-31. (Pubitemid 36535388)
87. Leriche M, Méndez M, Zimmer L, Bérod A (2008). Acute ethanol induces Fos in GABAergic and non-GABAergic forebrain neurons: a double-labeling study in the medial prefrontal cortex and extended amygdala. Neuroscience 153: 259-267.
88. Liang KC, Melia KR, Miserendino MJD, Falls WA, Campeau S, Davis M (1992). Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J Neurosci 12: 2302-2312.
89. Lister RG (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92(2): 180-185. (Pubitemid 17072893)
90. Lunga P, Herbert J (2004). 17b-oestradiol modulates glucocorticoid, neural and behavioural adaptations to repeated restrain stress in female rats. J Neuroendocrinol 16(9): 776-785. (Pubitemid 39307224)
91. Maguire J, Mody I (2009). Steroid hormone fluctuations and GABAAR plasticity. Psychoneuroendocrinology 34S: S84-S90.
92. Martel KL, Baum MJ (2009). Adult testosterone treatment but not surgical disruption of vomeronasal function augments male-typical sexual behavior in female mice. J Neurosci 29(24): 7658-7666.
93. Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonesca F, Raber J, Koob GF (1995). Increase of extracellular corticotropinreleasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15(8): 5439-5447.
94. Miller KE, Hoffman JH, Barnes GM, Sabo D, Melnick MJ, Farrell MP (2005). Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors*. Subst Use Misuse 40(11): 1637-1657. (Pubitemid 41444189)
95. Möhler H (2012). The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62: 42-53.
96. Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR (2004). Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science B 303(5663): 1512-1514. (Pubitemid 38314419)
97. Nie Z, Zorilla EP, Madamba SG, Rice KC, Roberto M, Siggins GR (2009). Presynaptic CRF1 receptors mediate the ethanol enhancement of GABAergic transmission in the mouse central amygdala. Sci World J 9: 68-85.
98. Oberlander JG, Porter DM, Penatti CA, Henderson LP (2012). Anabolic androgenic steroid abuse: multiple mechanisms of regulation of GABAergic synapses in neuroendocrine control regions of the rodent forebrain. J Neuroendocrinol 24(1): 202-214.
99. O'Connor LH, Cicero TJ (1993). Anabolic steroids: misuse or abuse? In: Schulkin, J (ed). Hormonally Induced Changes in Mind and Brain. Academic Press: San Diego, CA, pp 129-156.
100. Olive MF, Koenig HN, Nannini MA, Hodge CW (2002). Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 72: 213-220. (Pubitemid 34251330)
101. Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS (2006). Psychiatric side effects induced by supraphysiological does of combinations of anabolic steroids correlate to the severity of abuse. Eur Psychiatry 21: 551-562. (Pubitemid 44855525)
102. Paulmyer-Lacroix O, Héry M, Pugeat M, Grino M (1996). The modulatory role of estrogens on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of ovariectomized rats: the role of the adrenal gland. J Neuroendocrinol 8(7): 515-519. (Pubitemid 26239719)
103. Pelleymounter MA, Joppa M, Carmouche M, Cullen MJ, Brown B, Murphy B et al. (2000). Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. J Pharmacol Exp Ther 293: 799-806. (Pubitemid 30417844)
104. Penatti CA, Porter DM, Henderson LP (2009a). Chronic exposure to anabolic androgenic steroids alters neuronal function in the mammalian forebrain via androgen receptor-and estrogen receptor-mediated mechanisms. J Neurosci 29: 12484-12496.
105. Penatti CAA, Costine BA, Porter DM, Henderson LP (2009b). Effects of chronic exposure to an anabolic androgenic steroid mixture on a5-receptor-mediated GABAergic transmission and neural signaling in the forebrain of female mice. Neuroscience 161: 526-537.
106. Penatti CAA, Davis MA, Porter DM, Henderson LP (2010). Altered GABAA receptor-mediated synaptic transmission disrupts the firing of gonadotropin-releasing hormone neurons in male mice under conditions of steroid abuse. J Neurosci 30(19): 6497-6506.
107. Penatti CAA, Henderson LP (2009). Androgen Actions on Receptors and Channels: Regulation of Electrical Excitability and Synaptic Transmission. In Pfaff DW, Arnold A, Etgen A, Fahrbach S, Rubin R (eds). Hormones, Brain and Behavior, 2nd edn. Elsevier/Academic Press: Amsterdam, pp 1245-1274.
108. Penatti CAA, Oberlander JG, Davis MC, Porter DM, Henderson LP (2011). Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse. Neuropharmacology 61(4): 653-664.
109. Penatti CAA, Porter DM, Jones BL, Henderson LP (2005). Sexspecific effects of chronic anabolic androgenic steroid treatment on GABAA receptor expression and function in adolescent mice. Neuroscience 135(2): 533-543. (Pubitemid 41317390)
110. Peng IF, Berke BA, Zhu Y, Lee WH, Chen M, Wu CF (2007). Temperature-dependent developmental plasticity of Drosophila neurons: cell-autonomous roles of membrane excitability, Ca2+ influx, and cAMP signaling. J Neurosci 27(46): 12611-12622. (Pubitemid 350127815)
111. Perry PJ, Lund BC, Deninger MJ, Kutscher EC, Schneider J (2005). Anabolic steroid use in weightlifters and bodybuilders. Clin J Sport Med 15(5): 326-330.
112. Petrovich GD, Swanson LW (1997). Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit. Brain Res 763(2): 247-254. (Pubitemid 27364445)
113. Pinna G, Agis-Balboa RC, Pibiri F, Nelson M, Guidotti A, Costa E (2008). Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem Res 33: 1990-2007.
114. Pitkanen A (2000). Connectivity of the rat amygdaloid complex. In Aggleton JP (ed). The Amygdala: A Functional Analysis. 2nd edn. Oxford University Press: Oxford, UK, pp 31-116.
115. Polston EK, Gu G, Simerly RB (2004). Neurons in the principal nucleus of the bed nuclei of the stria terminalis provide a sexually dimorphic GABAergic input to the anteroventral periventricular nucleus of the hypothalamus. Neuroscience 123(3): 793-803. (Pubitemid 38045417)
116. Pope HG, Katz DL (1988). Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 145: 487-490. (Pubitemid 18099129)
117. Pope HG, Katz DL (1994). Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 51(5): 375-382. (Pubitemid 24176815)
118. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW (1992). The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 89: 4192-4196.
119. Rashid W (2000). Testosterone abuse and affective disorders. J Subst Abuse Treat 18(2): 179-184. (Pubitemid 30123101)
120. Rassnick S, Koob GF, Geyer MA (1992). Responding to acoustic startle during chronic ethanol intoxication and withdrawal. Psychopharmacology (Berl) 106(3): 351-358.
121. Rebaudo R, Melani R, Balestrino M, Izvarina N (2001). Electrophysiological effects of sustained delivery of CRF and its receptor agonists in hippocampal slices. Brain Res 922(1): 112-117. (Pubitemid 33152851)
122. Reddy DS (2010). Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186: 113-137.
123. Resstel LBM, Alves FHF, Reis DG, Crestani CC, Corrêa FMA, Guimarães FS (2008). Anxiolytic-like effects induced by reversible inactivation of the bed nucleus of stria terminalis. Neuroscience 154: 869-876.
124. Reul JM, Holsboer F (2002). Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2(1): 23-33.
125. Ricci LA, Rasakham K, Grimes JM, Melloni Jr RH (2006). Serotonin-1A receptor activity and expression modulate adolescent anabolic/androgenic steroid-induced aggression in hamsters. Pharmacol Biochem Behav 85(1): 1-11. (Pubitemid 44773721)
126. Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA (2003). Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology 170: 178-187. (Pubitemid 37421529)
127. Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA (2004). Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci 24: 6545-6552. (Pubitemid 38971703)
128. Risbrough VB, Geyer MA (2005). Anxiogenic treatments do not increase fear-potentiated startle in mice. Biol Psychiatry 57: 33-43. (Pubitemid 39647589)
129. Roberto M, Cruz MT, Gilpin NW, Sabino V, Schweitzer P, Bajo M et al. (2010). Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence. Biol Psychiatry 67(9): 831-839.
130. Roberto M, Madamba SG, Stouffer DG, Parsons LH, Siggins GR (2004). Increased GABA release in the central amygdala of ethanol-dependent rats. J Neurosci 24(45): 10159-10166. (Pubitemid 39492041)
131. Rocha VM, Calil CM, Ferreira R, Moura MJCS, Marcondes FK (2007). Influence of anabolic steroid on anxiety levels in sedentary male rats. Stress 10: 326-331. (Pubitemid 350125784)
132. Rojas-Ortiz YA, Rundle-González V, Rivera-Ramos I, Jorge JC (2005). Modulation of elevated plus maze behavior after chronic exposure to the anabolic steroid 17alpha-methyltestosterone in adult mice. Horm Behav 49(1): 123-128. (Pubitemid 41821877)
133. Sara Y, Virmani T, Deák F, Liu X, Kavalali ET (2005). An isolated pool of vesicles recycles at rest and drives spontaneous neurotransmission. Neuron 45(4): 563-573. (Pubitemid 40249868)
134. Sato SM, Schulz KM, Sisk CL, Wood RI (2008). Adolescents and androgens, receptors and rewards. Horm Behav 53: 647-658.
135. Schmued LC (1994). Diagonal ventral forebrain continuum has overlapping telencephalic inputs and brainstem outputs which may represent loci for limbic/autonomic integration. Brain Res 667: 175-191.
136. Schulz KM, Zehr JL, Salas-Ramirez KY, Sisk CL (2009). Testosterone programs adult social behavior before and during, but not after, adolescence. Endocrinology 150(8): 3690-3698.
137. Scicli AP, Petrovich GD, Swanson LW, Thompson RF (2004). Contextual fear conditioning is associated with lateralized expression of the immediate early gene c-fos in the central and basolateral amygdalar nuclei. Behav Neurosci 118(1): 5-14. (Pubitemid 38222519)
138. Schwartzer JJ, Ricci LA, Melloni Jr RH (2009). Adolescent anabolic-androgenic steroid exposure alters lateral anterior hypothalamic serotonin-2A receptors in aggressive male hamsters. Behav Brain Res 199(2): 257-262.
139. Sharp FR, Sagar SM, Swanson RA (1993). Metabolic mapping with cellular resolution: c-fos vs. 2-deoxyglucose. Crit Rev Neurobiol 7: 205-228. (Pubitemid 24181330)
140. Sheffield ME, Best TK, Mensh BD, Kath WL, Spruston N (2011). Slow integration leads to persistent action potential firing in distal axons of coupled interneurons. Nat Neurosci 14(2): 200-207.
141. Shekhar A, Truitt W, Rainnie D, Sajdyk T (2005). Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 8(4): 209-219. (Pubitemid 43163254)
142. Shen H, Gong HQ, Aoki C, Yuan M, Ruderman Y, Dattilo M et al. (2007). Reversal of neurosteroid effects at a4b2d GABAA receptors triggers anxiety at puberty. Nat Neurosci 10(4): 469-477. (Pubitemid 46494589)
143. Skórzewska A, Bidziński A, Hamed A, Lehner M, Turzyńska D, Sobolewska A et al. (2008). The influence of CRF and alpha-helical CRF(9-41) on rat fear responses, c-Fos and CRF expression, and concentration of amino acids in brain structures. Horm Behav 54(5): 602-612.
144. Steensland P, Blakely G, Nyberg F, Fahlke C, Pohorecky LA (2005). Anabolic androgenic steroid affects social aggression and fear-related behaviors in male pair-housed rats. Horm Behav 48: 216-224. (Pubitemid 41021820)
145. Smith SS, Aoki C, Shen H (2009). Puberty, steroids, and GABAA receptor plasticity. Psychoneuroendocrinology 345: S91-S103.
146. Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS et al. (2008). Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence. Biol Psychiatry 63: 139-145. (Pubitemid 350299311)
147. Su TP, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz O, Rubinow DR (1993). Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 269: 2760-2764. (Pubitemid 23154250)
148. Sun N, Cassell MD (1993). Intrinsic GABAergic neurons in the rat central extended amygdala. J Comp Neurol 330: 381-404. (Pubitemid 23095334)
149. Sun N, Roberts L, Cassell MD (1991). Rat central Amygdaloid Nucleus Projections to the Bed Nucleus of the Stria Terminalis. Brain Res Bull 27: 651-662.
150. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36(3): 165-186. (Pubitemid 13138041)
151. Swerdlow NR, Britton KT, Koob GF (1989). Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by a-helical CRF (9-41). Neuropsychopharmacology 2: 285-292. (Pubitemid 20025256)
152. Swerdlow NR, Geyer MA, Vale WW, Koob GF (1986). Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology 88: 147-152. (Pubitemid 16148127)
153. Thiblin I, Petersson A (2005). Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol 19(1): 27-44. (Pubitemid 40204345)
154. Trenton AJ, Currier GW (2005). Behavioural manifestations of anabolic steroid use. CNS Drugs 19: 571-595. (Pubitemid 41058370)
155. van Pett K, Viau V, Bittencourt JC, Chan RKW, Li HY, Arias C et al. (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191-212.
156. Veening JG, Böcker KB, Verdouw PM, Olivier B, De Jongh R, Groenink L (2009). Activation of the septohippocampal system differentiates anxiety from fear in startle paradigms. Neuroscience 163(4): 1046-1060.
157. Veinante P, Freund-Mercier M (1998). Intrinsic and extrinsic connections of the rat central extended amygdala: an in vivo electrophysiological study of the central amygdaloid nucleus. Brain Res 794(2): 188-198. (Pubitemid 28300451)
158. Veinante P, Stoeckel ME, Freund-Mercier MJ (1997). GABA-and peptide immunoreactivities co-localize in the rat central extended amygdala. Neuroreport 8: 2985-2989. (Pubitemid 27394831)
159. Walf AA, Frye CA (2007). The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2(2): 322-328. (Pubitemid 47040046)
160. Walker D, Yang Y, Ratti E, Corsi M, Trist D, Davis M (2009b). Differential effects of the CRF-R1 antagonist GSK876008 on fearpotentiated, light-and CRF-enhanced startle suggest preferential involvement in sustained vs. phasic threat responses. Neuropsychopharmacology 34: 1533-1542.
161. Walker DL, Miles LA, Davis M (2009a). Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry 33: 1291-1308.
162. Wasser CR, Ertunc M, Liu X, Kavalali ET (2007). Cholesteroldependent balance between evoked and spontaneous synaptic vesicle recycling. J Physiol 579(Pt 2): 413-429. (Pubitemid 46351759)
163. Wasser CR, Kavalali ET (2009). Leaky synapses: regulation of spontaneous neurotransmission in central synapses. Neuroscience 158(1): 177-188.
164. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP (1996). In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137(12): 5747-5750. (Pubitemid 26423152)
165. Westphal NJ, Seasholtz AF (2006). CRH-BP: the regulation and function of a phylogenetically conserved binding protein. Front Biosci 11: 1878-1891. (Pubitemid 43253401)
166. Wong ML, Webster EL, Spokes H, Phu P, Ehrhart-Bornstein M, Bornstein S et al. (1999). Chronic administration of the nonpeptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life Sci 65(4): PL53-PL58. (Pubitemid 29325290)
167. Yang P, Jones BL, Henderson LP (2002). Mechanisms of anabolic androgenic steroid modulation of a1b3g2L GABAA receptors. Neuropharmacology 43(4): 619-633.
168. Yang P, Jones BL, Henderson LP (2005). Role of the a subunit in the modulation of GABAA receptors by anabolic androgenic steroids. Neuropharmacology 49(3): 300-316. (Pubitemid 41112818)
169. Zender R, Olshansky E (2009). Women's mental health: depression and anxiety. Nurs Clin North Am 44: 355-364.
170. Zorrilla EP, Valdez GR, Nozulak J, Koob GF, Markou A (2002). Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res 952(2): 188-199.